RECEIVE REPORT STATUS AND QUICK ACCESS TO PATIENT INFORMATION /// EXPLORE NOW

img

Precision Medicine Company utilizing Advanced Molecular Diagnostics merged with Machine Learning.

Artificial Intelligence-powered treatment algorithms bringing specialist-level care and advanced capabilities to local community-based healthcare.

LEARN MORE

Precision Medicine Company utilizing Advanced Molecular Diagnostics merged with Machine Learning.

Artificial Intelligence-powered treatment algorithms bringing specialist-level care and advanced capabilities to local community-based healthcare.

LEARN MORE

Sign up to Receive updates

AI-enabled Precision medicine

Bringing the power of data and artificial intelligence to healthcare

Pathogen Testing Services

MEDUSA PATHOLOGY advanced molecular pathogen detection system identifies a vast majority of known human pathogens including those in urinary tract infections, gynecologic infections and sexually transmitted diseases, gastrointestinal infections, wound infections and nail infections as well as respiratory disease.

WHAT WE ALSO DO

CLINICAL DECISION SUPPORT

MEDUSA PATHOLOGY has laboratory physicians able to assist in test interpretation and provide guidance on utilization, treatment plans and recommendations on additional studies if needed.

LEARN MORE

ADVANCED DIGITAL PATHOLOGY SERVICES

MEDUSA PATHOLOGY is also a leader in digital pathology and we are currently expanding our team’s expertise in both computational image analysis as well as traditional telepathology services to support our clinicians.

LEARN MORE

LAB CONSULTATION SERVICES

In addition to our in house lab services, we also provide consultation services for laboratories looking to add these advanced capabilities to their facilities.

LEARN MORE

NOVEL COVERED BLADDER CANCER SCREENING ASSAY

In the wake of Medicare’s recent decision to discontinue coverage for Abbott’s Urovysion FISH testing, MEDUSA PATHOLOGY has partnered with KDX Diagnostics to provide a novel proprietary urine screening assay using Medicare covered immunohistochemistry codes that provides a more sensitive and specific test for bladder cancer screening.

LEARN MORE
WHY CHOOSE US

MEDUSA PATHOLOGY offers convenient, local 24-hour turnaround time with high quality customer service that includes on-call after hours support from our expert physician staff that separates our lab services from large commercial labs.

News & Articles

APRIL 2023

THE MOLECULAR ADVANTAGE

Urinary tract infections (UTIs) are among the most common infections in humans, with and estimated seven million patient visits and a cost of $1.6 billion USD per year.

By Dr. Brian Kelly, J Mass Spectrom Adv Clin Lab. 2023 Apr; 28: 60–62. READ MORE ➞
DECEMBER 2022

CHALLENGING THE UTI TESTING GOLD STANDARD

Though women and older adults are most vulnerable, many people will experience a urinary tract infection (UTI) during their lifetimes. These common infections of the urinary system impact the kidneys, bladder, or urethra. In the United States alone, UTIs account for more than 8 million doctor visits each year . Though not typically life threatening, UTIs can cause serious complications if left untreated and UTI-related hospitalizations cost an estimated $2.8 billion annually in the United States .

By Thermofisher Scientific, Dec 15, 2022 READ MORE ➞
MARCH 2023

UROLOGY TIMES: THE STATUS AND FUTURE DIRECTION OF ADVANCED URINE TESTING: MULTIPLEX PCR

More than half of adult women in the United States will have at least ? urinary tract infection (UTI) with an estimated annual cost burden of $1.6 billion. Among these women, 25% to 50% will develop recurrent UTI (rUTI), which is defined as at least 2 infections in a 6-month period or at least 3 in 1 year. The gold standard for UTI diagnosis is urinalysis and standard urine culture (SUC), where a positive result is defined as 105 colony forming units (CFU). Yet SUC has many shortcomings, including a false negative rate of 20% to 30% among symptomatic subjects.

By Stephanie Gleicher, MD, MPH and Roger Dmochowski, MD, FACS READ MORE ➞

MEDUSA PATHOLOGY

is CLIA certified